CAELUS’ Post

Improved radionuclide supply can transform nuclear medicine https://lnkd.in/eyTcTnCG

Best invest in Building and talking about Fusion power, space, maritime propulsion systems and industry as data centres are. Great Headline, Guardian on Nuclear fission. https://lnkd.in/g8sMZtpR People talk about Nuclear (meaning Fission) and fail to discuss fusion. https://lnkd.in/ge_aeX7M The nuclear fission industry is ignorant of what's happening around it. It must pull its collective uranium heads out of the sand and prepare to enter the commercially growing fusion energy industry. Fission is moving towards obsolescence at an ever-increasing pace, as it is "out of step, out of time, out of place, and soon to be out of Fuel" and merely temporary. https://lnkd.in/gbd_mZqk By 2028, Helion is expected to start producing electricity from its first fusion commercial power plant, which will provide electricity to Microsoft. The plant will produce at least 50 MWe after an initial ramp-up period. https://lnkd.in/gY9J3MQY Now, see what is happening in the world of the fusion industry. https://lnkd.in/g9hMBD7a As fission trebles, fuel shortage is increasingly real, https://lnkd.in/gze5rwpr

📣⚛️ Advancing Healthcare - Exploring the Frontiers of Nuclear Medicine 📰📣 👩⚕️⚛️🔬 Check out our latest interview with Dr Sarah Baatout, Deputy Director of the Nuclear Medical Applications Institute at the Belgian Nuclear Research Centre SCK CEN (ENS Corporate Member). 💊⚛️❤️ In this interview, Dr Baatout shares valuable insights into the current trends, challenges, and future directions in #nuclear #medicine and #radiopharmaceuticals. From personalized approaches to targeted therapies, nuclear medicine is revolutionizing #patientcare. Discover more about the fascinating advancements in this field and the importance of supporting the entire supply chain to ensure access to cutting-edge #diagnoses and #treatments for all #patients. ▶️ Read the full interview here: https://lnkd.in/dzi6QGgd #NuclearMedicine #Radiopharmaceuticals #HealthcareInnovation #PersonalizedMedicine #PatientCare #Interview #Healthcare #Research #NuclearScience #MedicalTechnology

Join us at the European Association of Nuclear Medicine (EANM) in Vienna, Austria, 9-13 September, where Curium experts will be on hand to discuss insights on the latest patient care advancements.   Come visit us at booth #313 to learn more about Curium's products and innovations in the field of nuclear medicine. Save the date for 11th September 13:15 CEST for our symposium by a panel of experts: ‘PYLCLARI® (Piflufolastat (18F)) now in Europe: Sharing current perspectives on the diagnosis of prostate cancer’.   We're looking forward to the opportunity to connect, collaborate, and learn with you.   https://lnkd.in/euMPxsyw    #NuclearMedicine #ProstateCancer #NuclearImaging #CancerDiagnosis #preventivemedicine #PET #SPECT #radiopharmaceuticals #Congress #EANM23 #NucMed #CuttingEdgeResearch #ViennaCalling #EANM23Updates

PanMediso Holdings has been committed to promoting the research and innovation of isotope nuclear medicine, and continues to pay attention to and support innovative development in the industry. Recently, news about isotope-related innovations has attracted strong attention in the field of nuclear medicine. 1.[ARTBIO announced the completion of an excess Series A financing of more than US$90 million. F-Prime Capital and Omega Funds, the leading institutions in the seed round, also significantly participated in this financing. ] 2.[Ractigen Therapeutics’ RAG-01 became the second saRNA drug in the world to enter the clinical stage and the first saRNA drug in China to achieve this milestone. ] 3. [Lepu Biopharma's independently developed EGFR-targeted ADC product MRG003 has been granted fast track status by the FDA, providing new hope for the treatment of advanced nasopharyngeal cancer (NPC). ] 4. [CARsgen's CT071 received IND approval from the FDA and became a CAR-T cell product candidate for relapsed/refractory multiple myeloma or relapsed/refractory primary plasma cell leukemia. ] 5. [China National Nuclear Corporation successfully independently developed kilogram-level 99% abundance molybdenum-100 isotope, achieving independent supply of key molybdenum isotope materials in China]   PanMediso Holdings keenly grasped that this is a clear signal that the field of isotope nuclear medicine is ushering in a new round of high attention. By continuing to pay attention to market needs, we strive to find and promote more forward-looking innovation opportunities to meet patient and market needs. #isotope #nuclearmedicine

It’s Nuclear Medicine and Molecular Imaging Week. This week, we join the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in recognizing the remarkable contributions of nuclear medicine professionals. The theme, ‘Saving Lives with Half-Lives,’ highlights the transformative potential of radiopharmaceuticals in patient care. At Curium, we're proud to be a part of this vital field. Our commitment to healthcare innovation drives us to develop solutions that empower healthcare providers with precise diagnostics and personalized treatments. Together, we are redefining the experience of cancer through our trusted legacy in nuclear medicine. Learn more about Nuclear Medicine and Molecular Imaging Week: https://lnkd.in/d63A6m68 #NuclearMedicineAndMolecularImagingWeek #NuclearMedicine #NuclearImaging #SNMMI #NucMed #Radiopharmaceuticals

Nuclear Fun Fact : Nuclear medicine and radiation therapy are two ways nuclear technologies are used to treat cancer. In nuclear medicine, radioactive substances are introduced into the body to target and destroy cancer cells. Radiation therapy, on the other hand, uses high-energy radiation to shrink or eliminate tumors. Both approaches aim to selectively target and damage cancer cells while minimizing harm to healthy tissues.

Nuclear Fun Fact : Nuclear medicine and radiation therapy are two ways nuclear technologies are used to treat cancer. In nuclear medicine, radioactive substances are introduced into the body to target and destroy cancer cells. Radiation therapy, on the other hand, uses high-energy radiation to shrink or eliminate tumors. Both approaches aim to selectively target and damage cancer cells while minimizing harm to healthy tissues.